Miller-Meeks Appointed to Coronavirus Subcommittee
WASHINGTON, D.C.—Today, March 19th, 2021, Rep. Mariannette Miller-Meeks (IA-02) announced her appointment to the House Select Subcommittee on the Coronavirus Crisis. Miller-Meeks will serve on the Select Subcommittee in addition to her appointments on the Committees on Homeland Security, Education and Labor, and Veterans’ Affairs.
“Congress’ top priority must be combatting COVID-19, getting Americans vaccinated so that our lives can return to normal with family get-togethers, reopening our schools and our economy, and preparing for possible future pandemics. As a physician, the former Director of the Iowa Department of Public Health, and the former President of the Iowa Medical Society, I am honored to have been chosen as a member of the Select Subcommittee on the Coronavirus Crisis,” said Miller-Meeks. “As we continue to crush the pandemic caused by COVID-19, I look forward to working with my colleagues to deliver real results for Americans.”
“Representative Miller-Meeks’ service in the U.S. Army, leading the Iowa Medical Society, and tenure as the Director of the Iowa Department of Public Health, makes her uniquely qualified to serve on the Select Subcommittee on the Coronavirus Crisis and help us solve the problems American families are facing,” said House Republican Whip Steve Scalise, Ranking Member of the Select Subcommittee. “I welcome Representative Miller-Meeks to the Select Subcommittee and look forward to working with her throughout the 117th Congress as we push to safely reopen our schools and businesses and get back to normalcy.”
“To effectively battle the coronavirus and ensure taxpayer funds are spent efficiently, effectively, and transparently requires individuals with a deep understanding of the issue at hand. Congresswoman Mariannette Miller Meeks’ immense experience as a doctor in both the United States Army and in private practice gives her a unique perspective among members of Congress," said House Republican Leader Kevin McCarthy. "That is why I am honored to have appointed her to serve on the Select Subcommittee on the Coronavirus Crisis, where her skill set and intelligence will be crucial in making sure Americans’ tax dollars are spent responsibly in the fight against the virus.”
The House has charged the Select Subcommittee on the Coronavirus Crisis with examining:
(1) the efficiency, effectiveness, equity, and transparency of the use of taxpayer funds and relief programs to address the coronavirus crisis, including through Federal agencies, State and local government entities, financial institutions and other private businesses, contracts, grants, loans, loan guarantees, investments, cooperative agreements, or any other means;
(2) reports of waste, fraud, abuse, price gouging, profiteering, or other abusive practices related to the coronavirus crisis;
(3) the implementation or effectiveness of any Federal law applied, enacted, or under consideration to address the coronavirus crisis and prepare for future pandemics;
(4) preparedness for and response to the coronavirus crisis, including the planning for and implementation of testing, containment, mitigation, and surveillance activities; the acquisition, distribution, or stockpiling of protective equipment and medical supplies; and the development of vaccines and treatments;
(5) the economic impact of the coronavirus crisis on individuals, communities, small businesses, health care providers, States, and local government entities;
(6) any disparate impacts of the coronavirus crisis on different communities and populations, including with respect to race, ethnicity, age, sex, gender identity, sexual orientation, disability, and geographic region, and any measures taken to address such disparate impacts;
(7) executive branch policies, deliberations, decisions, activities, and internal and external communications related to the coronavirus crisis;
(8) the protection of whistleblowers who provide information about waste, fraud, abuse, or other improper activities related to the coronavirus crisis;
(9) cooperation by the executive branch and others with Congress, the Inspectors General, the Government Accountability Office, and others in connection with oversight of the preparedness for and response to the coronavirus crisis; and
(10) any other issues related to the coronavirus crisis.